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938Objectives: Patients often present for aortic root replacement surgery with concomitant mitral valve pathology.
Moderate mitral regurgitation is the point of clinical equipoise where the benefits of intervention compared with
observation are currently unknown. This study compares outcomes in patients undergoing aortic root replace-
ment surgery who did or did not receive a mitral valve repair for their preoperativemoderate mitral regurgitation.
Methods:A total of 1316 patients who underwent aortic root replacement surgery between 2000 and 2011 were
evaluated, with 104 patients meeting the inclusion criteria by presenting with moderate preoperative mitral
regurgitation. A total of 73 patients (70%) received no mitral intervention, and 31 patients (30%) received
a mitral repair. Patients underwent preoperative, postoperative, and greater than 6-month follow-up echo-
cardiograms. Average clinical follow-up was 6.5 years.
Results: The mitral repair group had increased preoperative New York Heart Association III/IV and heart
failure, longer crossclamp times, and more postoperative renal failure (P ¼ .0003, P ¼ .04, P< .0001, and
P ¼ .03, respectively). The improvement in mitral regurgitation was greater for the mitral repair group
(2.1  0.3 vs 1.1  0.8, P<.0001), and mitral regurgitation remained significantly lower on follow-up at
6 months or more (0.6  0.4 0.9  0.2, P ¼ .002). A significantly greater percentage of patients undergoing
mitral repair compared with patients with no repair had improvement of at least 1 grade in mitral regurgitation
postoperatively (100% vs 70%, P ¼ .001) and on follow-up at 6 months or more (90% vs 61%, P ¼ .006).
There was no difference in long-term survival, freedom from 2þ or greater mitral regurgitation, or mitral
reinterventions.
Conclusions: Mitral repair along with aortic root replacement has acceptable operative risk. Aortic root
replacement surgery alone improved mitral regurgitation, but the addition of mitral repair further reduced mitral
regurgitation, suggesting that repairing moderate mitral regurgitation should generally be considered along with
aortic root replacement. (J Thorac Cardiovasc Surg 2014;147:938-41)Patients frequently present with both aortic and mitral valve
pathology. In published series of aortic valve replacement
(AVR), as many as 61% to 90% of patients have some
degree of mitral regurgitation (MR).1 Patients undergoing
aortic root replacements also frequently present with MR
because many of the degenerative diseases of the aortic
root also affect the mitral valve.2 Consensus exists that
severe MR requires intervention at the time of aortic
intervention, but there is ongoing debate regarding the
benefit of intervening on less severe MR. Recent literature
also suggests that when mitral intervention is undertakene Department of Cardiovascular Surgery, Hospital of the University of
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The Journal of Thoracic and Cardiovascular Surgfor MR, mitral valve repairs are likely more beneficial
than mitral valve replacements.3 Clinical equipoise still
exists whether the conservative approach of observation
or the interventional approach of mitral repair is best for
patients with moderate MR undergoing aortic valve
intervention. This study compares echocardiographic and
clinical outcomes in patients undergoing aortic root
replacement surgery who did or did not receive a mitral
valve repair for their preoperative moderate MR.
PATIENTS AND METHODS
The institutional review board at the University of Pennsylvania
approved the study and waived the need for patient consent. A total of
1316 patients who underwent aortic root replacement surgery between
January 2000 and December 2011 were evaluated. Exclusion criteria
included mitral stenosis, endocarditis, aortic dissection, and mitral
replacement. A total of 104 patients met the inclusion criteria and presented
preoperatively with moderate MR, defined as greater than mild (1þ) and
less than severe (4þ). A total of 73 patients (70%) received no mitral
intervention, and 31 patients (30%) received a mitral repair.
All patients underwent preoperative and postoperative echocardio-
grams. Preoperative transthoracic echocardiograms (TTEs) were preferen-
tially selected for all echocardiograms to provide consistent
loading conditions and comparable parameters without the confounding
effect of general anesthesia on the severity of MR. Transesophagealery c March 2014
Abbreviations and Acronyms
AVR ¼ aortic valve replacement
CABG ¼ coronary artery bypass grafting
MR ¼ mitral regurgitation
TTE ¼ transthoracic echocardiogram
McCarthy et al Acquired Cardiovascular Diseaseechocardiograms were used when TTEs were unavailable. Preoperative
TTEs had to be performed within 6 months of the date of surgery.
Postoperative TTEs had to occur before the patient left the hospital.
Greater than 6-month echocardiograms were obtained on 62% (n ¼ 65)
of patients with an average echocardiographic follow-up time of 3.3 years.
If more than 1 follow-up echocardiogram was available, the most recent
examination was used to show the greatest degree of ventricular
remodeling, hemodynamic changes, and stability of mitral repairs. Data
points were extrapolated from echocardiogram reports using the MR
grades of mild (1þ), mild-moderate (1.5þ), moderate (2þ), moderate-
severe (3þ), and severe (4þ). Median clinical follow-up was 6.5 years.
Statistical analysis was carried out using SPSS 19 (SPSS Inc, Chicago
Ill). Categoric variables were compared using chi-square tests with the
Fisher exact test. Continuous variables were analyzed using the Student
t test. For comparison of changes in ordinal categories, nonparametric
Mann–Whitney tests were conducted. Long-term mortality and freedom
from late events were computed using Kaplan–Meier estimators and
log-rank tests.A
C
DRESULTS
The mitral repair group had increased incidence of
preoperative New York Heart Association III/IV (63.6%
vs 31.5%, P< .001) and heart failure (78.7% vs 64.3%,
P ¼ .04). There were no other significant differences in
patient characteristics, preoperative comorbid conditions,
or previous cardiothoracic interventions. Operative charac-
teristics and perioperative outcomes are detailed in Table 1.
The repair group had a higher percentage of mixed aortic
insufficiency/stenosis than the no repair group (36.3% vs
19.1%, P ¼ .047). The presenting cause of mitral diseases
was different for both groups, with fewer functional (45%
vs 75%, P ¼ .007) and increased number of myxomatous
(32% vs 10%, P ¼ .01) and rheumatic (10% vs 0%,
P ¼ .02) mitral valves in the repair group. Crossclamp
time was increased in the repair group (244.8  42 vs
179.6 50.6, P<.0001), as was postoperative renal failure
(9% vs 1.3%,P¼ .03) despite no difference in preoperative
renal failure (3% vs 8.2%, P¼ .43). There were 3 operative
deaths in the no repair group and zero operative deaths in
the repair group, but this difference was not statistically
significant.
The mean improvement in MR was greater in the mitral
repair group compared with the no repair group postopera-
tively (2.1  0.3 vs 1.1  0.8, P<.0001) and at more
than 6-month follow-up (1.8  0.6 vs 1.3  0.5,
P < .0001). Mean MR remained significantly lower on
more than 6-month follow-up (0.6  0.4 0.9  0.2,
P ¼ .002). A significantly greater percentage of those
receiving mitral repair compared with no repair hadThe Journal of Thoracic and Caimprovement of at least 1 grade in MR postoperatively
(100% vs 70%, P ¼ .001) and at more than 6-month
follow-up (90% vs 61%, P ¼ .006) (Figure 1). There was
no difference in MR improvement in either group depend-
ing on the cause of the presenting MR, the type of repair,
or concomitant coronary artery bypass grafting (CABG).
The long-term clinical outcomes of freedom from 2þ or
greater MR were 100%, 98.5%  1.5%, 96.5%  2.5%,
and 96.5%  2.5% in the no repair group at 1, 3, 5, and
8 years, respectively, and 93.2%  4.7% for all time
points in the repair group (P ¼ .32). Freedom from mitral
interventions was 100%, 100%, 97.9%  2.1%, and
97.9%  2.1% at 1, 3, 5, and 8 years, respectively, in the
no repair group and 96.4%  3.4% for all time points in
the repair group (P ¼ .49). Survival was 94.5%  3%,
90.2%  4%, 83.2%  4.7%, and 81.2%  5% at 1, 3,
5, and 8 years, respectively, in the no repair group and
93.4%  4.5%, 90.1%  5.4%, 90.1%  5.4%, and
67.3%  16.3% at 1, 3, 5, and 8 years, respectively, in
the repair group (P ¼ .93). There was a trend toward worse
survival in the mitral repair group, although this difference
is not statistically significant. There was 1 repair failure at
9 months leading to a mitral valve replacement. Two
patients receiving no repair underwent mitral repair at
1 and 4.5 years after root replacement.
DISCUSSION
Patients frequently present with both aortic and mitral
valve pathology. Management of double-valve disease
remains clinically and technically challenging. The
presence of MR affects operative planning for both mitral
and aortic valves, because MR has been associated with
decreased survival and increased mortality risk in AVR
and aortic root replacement.4 Some hesitancy exists to
perform concomitant mitral valve interventions, because
some MR has been shown to improve with AVR alone,
and simultaneous aortic and mitral valve procedures have
been associated with a 2-fold increase in mortality over
isolated AVR.5 On the other hand, unaddressed MR after
AVR also has significant consequences and has been
associated with increased long-term mortality.6
Consensus exists that severe MR requires intervention,
but there is ongoing debate regarding less severe MR. Trace
or minimal MR is mostly observed with the expectation that
MR improves with aortic valve intervention alone.7 Clinical
equipoise exists on the best approach to the patient with
moderate MR undergoing aortic intervention. A number
of series have evaluated moderate MR for patients
undergoing AVR, but the issue of comparing intervention
with observation has yet to be explored in patients
undergoing aortic root replacement. Considering the
increased operative complexity of aortic root replacement
and the potential for aortic root replacements to affect the
aortomitral continuity, the decision to perform concomitantrdiovascular Surgery c Volume 147, Number 3 939
TABLE 1. Operative characteristics and outcomes
Primary aortic
indication
Mitral repair
(n ¼ 31)
No mitral
repair (n ¼ 73)
P
value
Aneurysm 60.6% (20) 67.1% (49) .83
AI 45.4% (15) 57.5% (42) .39
AS 12.1% (4) 5.4% (4) .23
Mixed AI/AS 36.3% (12) 19.1% (14) .047
Redo root 18.1% (6) 13.6% (10) .55
MR cause
Functional 14 (45%) 54 (73%) .007
Myxomatous 10 (32%) 7 (10%) .01
Ischemic 4 (13%) 12 (16%) .77
Rheumatic/other 3 (10%) 0 (0%) .02
Operation status
Elective 72.7% (24) 58.9% (43) .13
Urgent 15.1% (5) 34.2% (25) .11
Emergency 6% (2) 2.7% (2) .59
Concomitant procedure
CABG 15.1% (5) 16.4% (12) 1.00
Hemi/total arch 45.4% (15) 46.5% (34) 1.00
Tricuspid 3% (1) 6.8% (5) .66
Maze 3% (1) 4.1% (3) 1.00
Outcome
Crossclamp time (min) 244.8  42 179.6  50.6 <.0001
Reoperative bleeding 6% (2) 4.1% (3) .65
Perioperative myocardial
infarction
0% (0) 1.3% (1) 1.00
Deep sternotomy infection 3% (1) 0% (0) .31
Infection, septicemia 3% (1) 1.3% (1) .23
Stroke permanent 0% (0) 1.3% (1) 1.00
Stroke transient 0% (0) 1.3% (1) 1.00
Vent prolonged 30.3% (10) 20.5% (15) .22
Renal failure 9% (3) 1.3% (1) .03
Dialysis 3% (1) 1.3% (1) .53
Anticoagulant event 0% (0) 0% (0) 1.00
Tamponade 0% (0) 1.3% (1) 1.00
Gastrointestinal event 6% (2) 2.7% (2) .59
Atrial fibrillation 12.1% (4) 19.1% (14) .79
Heart block 15.1% (5) 10.9% (8) .54
Pneumonia 9% (3) 2.7% (2) .17
Mortality 0% (0) 4.1% (3) .55
AI, Aortic insufficiency; AS, aortic stenosis; CABG, coronary artery bypass grafting;
MR, mitral regurgitation.
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Dmitral repair for moderate MR at the time of aortic root
replacement remains a challenging clinical question.
This study demonstrates good short- and long-term
outcomes for aortic root replacements in patients with
moderate MR, which is a group previously shown to be at
higher surgical risk for both aortic root replacement and
AVR.2,7,8 Operative mortality was 2.8% for both groups
with zero operative deaths in the mitral repair group. Of
the 31 patients who underwent a repair, at more than
6 months follow-up 1 patient had worse MR, 1 patient
had return of moderate MR, and the remainder had mild
MR or less. There was a trend toward worse long-term
survival in the mitral repair group. This difference was940 The Journal of Thoracic and Cardiovascular Surgnot statistically significant, and it is difficult to interpret
this trend in the setting of an increased proportion of New
York Heart Association III/IVand heart failure in the mitral
repair group.
The group of patients who did not undergo mitral repair
also demonstrated improvement in MR postoperatively and
at more than 6 months. These results are consistent with
other studies that have shown significant MR improvement
with isolated AVR or AVR and CABG. In the no mitral
repair group, 80% of patients demonstrated postoperative
improvement in MR and 60% had 0þ or 1þ MR at
more than 6 months follow-up. The results show more
improvement in MR than some other AVR studies.1,9 One
explanation for this could be the additional aortomitral
continuity support provided by aortic root replacement.
The observed group also did not demonstrate any
significant short- or long-term clinical morbidity or
mortality as a result of a conservative approach to managing
their moderate MR.
With regard to the cause of the MR and concomitant
procedures performed, mitral repair was attempted in
59% (n ¼ 10) of patients with myxomatous disease, and
all myxomatous repairs had mild or less MR post-
operatively and at more than 6 months except 1 patient
with 2þMR detected at 2 years. Of the patients presenting
with functional MR, 79% were observed with no mitral
repair, but of those patients undergoing repair (n ¼ 14),
similar improvement in MR as the repaired myxomatous
valves was demonstrated. This study also included ischemic
MR and patients who underwent concomitant CABG. This
is potentially a confounding factor, because ischemic
MR has been shown to improve with CABG.9 In this study,
there was no difference in the number of ischemic and
concomitant CABG cases in the repair and no repair groups
or any increased improvement in MR when compared with
nonischemic cases.
A number of studies have attempted to define which
group of patients with MR will improve with just aortic or
aortic and CABG interventions.1,8,10 These studies have
not arrived at a reproducible set of similar preoperative
factors that can be used to predict whose MR will
improve without mitral valve intervention and indeed
often have contradictory results. Failing to intervene on
MR during aortic root replacement has the potential to
subject the patient to the increased risk of ongoing MR
and possible redo sternotomy if further mitral intervention
is required. The surgeon also faces the increased technical
difficulty of a mitral intervention with an aortic root
replacement already present.
In this study, both repair and observation cohorts had
good clinical outcomes, so no absolute indication for mitral
valve repair or observation of moderate MR in aortic root
replacement can be reasonably concluded on the basis of
the degree of MR alone. Intervention remains dependentery c March 2014
FIGURE 1. Change in mitral regurgitation (MR). Preop, Preoperative; postop, postoperative.
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Don clinical context, patient comorbidities, left ventricle and
left atrial dimensions, cause of MR, and concomitant
procedures. For patients who cannot tolerate a larger
operation, are undergoing concomitant CABG, or have a
dilated left ventricle or atrium, observation is an acceptable
decision. It is the recommendation of this group to repair all
myxomatous valves with true leaflet pathology and
moderate MR in the setting of aortic root replacement.
For patients with functional MR and preserved left
ventricular and left atrial geometry, repair is reasonable
and may yet offer further clinical benefit of reduced or
absent MR demonstrated in other studies.7,8 On the
whole, it is our practice to perform mitral repair for
moderate MR when possible to achieve the best mitral
outcomes, knowing that it does not increase surgical risk.Study Limitations
This is a retrospective study with significant differences
in the preoperative characteristics and causes of the MR
between the repair and no repair groups. Long-term
echocardiographic follow-up was not routinely obtained
or available for all patients. This potentially creates a bias
for obtaining echocardiograms in patients who had a
clinical event or decompensation, but there is no clear
reason why one group would be preferentially subject to
this bias. MR grades were extracted from reports
generally based on Doppler jets and not on more rigorous
single-reviewer and vena contracta measurements. Further
division of the repair and no repair groups into different
causes, preoperative characteristics, and postoperative
outcomes made multivariate analysis limited by small
group sizes, but this is still the largest study we could find
that addresses the specific but challenging question of
management and outcomes of moderate MR in aortic root
replacement surgery.The Journal of Thoracic and CaCONCLUSIONS
Despite increased heart failure and preoperative risk,
mitral repair along with aortic root replacement had
superior mitral valve outcomes, zero operative deaths, and
equivalent long-term clinical outcomes compared with
the no mitral repair group. This suggests that repairing
moderate MR generally should be considered at the time
of aortic root replacement surgery.References
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